Chongqing Lummy Pharmaceutical Co Ltd
SZSE:300006
Wall Street
Price Targets
Price Targets Summary
Chongqing Lummy Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Chongqing Lummy Pharmaceutical Co Ltd
is 10.78 CNY
.
Price Targets
Revenue
Forecast
Revenue Estimate
Chongqing Lummy Pharmaceutical Co Ltd
For the last 8 years the
compound annual growth rate for
Chongqing Lummy Pharmaceutical Co Ltd's revenue is
-1%.
The projected
CAGR
for the next 5 years is
12%.
Operating Income
Forecast
Operating Income Estimate
Chongqing Lummy Pharmaceutical Co Ltd
For the last 8 years the
compound annual growth rate for
Chongqing Lummy Pharmaceutical Co Ltd's operating income is
-2%.
The projected
CAGR
for the next 8 years is
-8%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Chongqing Lummy Pharmaceutical Co Ltd's stock price target?
Price Target
10.78
CNY
According to Wall Street analysts, the average 1-year price target for
Chongqing Lummy Pharmaceutical Co Ltd
is 10.78 CNY
.
What is Chongqing Lummy Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Chongqing Lummy Pharmaceutical Co Ltd's revenue is
-1%.
The projected
CAGR
for the next 5 years is
12%.
What is Chongqing Lummy Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-8%
For the last 8 years the
compound annual growth rate for
Chongqing Lummy Pharmaceutical Co Ltd's operating income is
-2%.
The projected
CAGR
for the next 8 years is
-8%.
You don't have any saved screeners yet
